The Mechanism of the Liver Catalase Depressing Action of Tumours in Mice

por Adams, D. H.
Publicado 1950

Mouse Liver Catalase. The Antagonistic Effect of Tumour Tissue upon the Hormonal Control Mechanisms

por Adams, D. H.
Publicado 1951

Further Observations on the Liver Catalase Depressing Action of Tumours

por Adams, D. H.
Publicado 1951

Some Studies on Liver Catalase in Embryonic and Immature Chickens and Mice

por Adams, D. H.
Publicado 1953

On the Failure of Tumour Homogenate Injections to Simulate Quantitatively the Changes in Catalase Activity in the Tumour-bearing host

por Adams, D. H.
Publicado 1961

The Action of Tumours on Their Hosts

por Adams, D. H.
Publicado 1961

Sex Differences in Tissue Catalase Levels, and Their Relation to the Catalase-Depressing action of Tumours

por Adams, D. H.
Publicado 1956

The Effect of Sarcoma 37 on the Intracellular Distribution of Mouse Liver Catalase

por Adams, D. H.
Publicado 1959

The Effect of the Degree of Homogenization on the Catalase Activity of Liver “Homogenates”

por Adams, D. H., Burgess, E. Ann
Publicado 1957

Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metas...

por Yoong, K. F., Adams, D. H.
Publicado 1998

The Action of Some Chemical Substances on Mouse Liver Catalase Activity in vivo

por Adams, D. H., Roe, F. J. C.
Publicado 1953

Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an αvβ3-independent manner

por Edwards, S, Lalor, P F, Tuncer, C, Adams, D H
Publicado 2006

The Effect of Tumours, of Leukaemia, and of Some Viruses Associated with them, on the Plasma Lactic Dehydrogenase Activity of Mice

por Adams, D. H., Rowson, K. E. K., Salaman, M. H.
Publicado 1961

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis.

por Adams, D. H., Yannelli, J. R., Newman, W., Lawley, T., Ades, E., Rosenberg, S. A., Shaw, S.
Publicado 1997

Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, T(reg) survival and CTLA‐4‐dependent function in autoimmune liver diseases

por Jeffery, H. C., Jeffery, L. E., Lutz, P., Corrigan, M., Webb, G. J., Hirschfield, G. M., Adams, D. H., Oo, Y. H.
Publicado 2017

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens

por Steele, J C, Torr, E E, Noakes, K L, Kalk, E, Moss, P A, Reynolds, G M, Hubscher, S G, van Lohuizen, M, Adams, D H, Young, L S
Publicado 2006

The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer

por Ward, S T, Li, K K, Hepburn, E, Weston, C J, Curbishley, S M, Reynolds, G M, Hejmadi, R K, Bicknell, R, Eksteen, B, Ismail, T, Rot, A, Adams, D H
Publicado 2015